Effectiveness of metronomic chemotherapy on metastatic breast cancer?


Question from RebeccaJ-2: Were there any updates on the effectiveness of metronomic chemotherapy on metastatic breast cancer, both with and without bevacizumab? Thanks.
Answers - Kathy D. Miller, M.D. Metronomic therapy is an approach that uses much lower doses of chemotherapy administered more frequently as a way of inhibiting the growth of blood vessels that may help the tumor grow. This has been most commonly studied using chemotherapy medicines called Cytoxan (chemical name: cyclophosphamide) and methotrexate (brand names: Amethopterin, Mexate, Folex). Those drugs are often given in higher doses as an IV infusion, but they can also be given in lower doses in pill form that would allow women to take the therapy more frequently. In previous studies, that combination has been effective in some women with metastatic disease and was more likely to be effective when combined with Avastin. But I didn't see any new studies of this approach reported at this year's meeting.

On Tuesday, December 15, 2009, our Ask-the-Expert Online Conference was called Updates from the 2009 San Antonio Breast Cancer Symposium. Kathy Miller, M.D. and Kristin Brill, M.D., F.A.C.S. answered your questions about the latest updates on breast cancer risk, screening techniques, treatment options, and more.

The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.

Was this resource helpful?

Yes No
C3a
C3b
Evergreen-donate
Back to Top